BiVACOR

BiVACOR, Inc. is a privately held, clinical-stage medical device company with corporate operations in Huntington Beach, California, clinical operations in Houston, Texas, and engineering operations on the Gold Coast, Queensland, Australia. It develops the BiVACOR Total Artificial Heart (TAH), a titanium biventricular rotary blood pump built around a single magnetically levitated rotor with a dual-sided impeller that replaces both ventricles of a failing heart, with no valves, flexing diaphragms or mechanical bearings, and flows above 12 L/min. Founded by Chief Technical Officer Daniel Timms, PhD, and led by CEO Jim Dillon with Chief Medical Officer William E. Cohn, MD, the company completed the first-in-human implantation at The Texas Heart Institute in July 2024 under an FDA Early Feasibility Study, received FDA Breakthrough Device Designation in May 2025, and was accepted into the FDA Total Product Life Cycle Advisory Program in August 2025. The TAH is an investigational device, limited by federal law to investigational use, and is not approved for commercial sale. BiVACOR is a medical hardware and clinical-research business - it publishes no developer program, public API, SDK, or machine-readable API contract.

BiVACOR is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Health Care, Cardiology, and Heart Failure.

BiVACOR’s developer surface includes engineering blog, support, and 12 more developer resources.

🌐 Visit website 📡 Source on GitHub

8.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-17 · rubric v0.11.0

0 APIs

CompanyMedical DevicesHealth CareCardiologyHeart FailureTotal Artificial HeartMechanical Circulatory SupportMedical TechnologyClinical Trials

Kin Score

Kin Score How this is scored →
scored 2026-08-17 · rubric v0.11.0

Composite quality — 8.1/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 1.1 / 17

Commercial Clarity 0.0 / 17

Operational Transparency 0.0 / 11

Governance 0.0 / 10

Discoverability 4.9 / 9

Regulatory Posture 2.1 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/bivacor: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt

LLMsTxt

Design & Contract 1

Pagination, idempotency, versioning, errors, and events

Conformance

Conformance

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 2

Status, limits, changes, and where to get help

Contact

Contact

Support

Support

Company 7

The organization behind the API

Website

Blog

BlogRSS

Press

Careers

LinkedIn

Twitter

Twitter

Scroll for all 7

Other 2

Properties that don't map to a standard resource type

Publications

Publications

SecondaryMarket

SecondaryMarket

Source (apis.yml)

aid: bivacor
name: BiVACOR
description: BiVACOR, Inc. is a privately held, clinical-stage medical device company with corporate operations in Huntington
  Beach, California, clinical operations in Houston, Texas, and engineering operations on the Gold Coast, Queensland, Australia.
  It develops the BiVACOR Total Artificial Heart (TAH), a titanium biventricular rotary blood pump built around a single magnetically
  levitated rotor with a dual-sided impeller that replaces both ventricles of a failing heart, with no valves, flexing diaphragms
  or mechanical bearings, and flows above 12 L/min. Founded by Chief Technical Officer Daniel Timms, PhD, and led by CEO Jim
  Dillon with Chief Medical Officer William E. Cohn, MD, the company completed the first-in-human implantation at The Texas
  Heart Institute in July 2024 under an FDA Early Feasibility Study, received FDA Breakthrough Device Designation in May 2025,
  and was accepted into the FDA Total Product Life Cycle Advisory Program in August 2025. The TAH is an investigational device,
  limited by federal law to investigational use, and is not approved for commercial sale. BiVACOR is a medical hardware and
  clinical-research business - it publishes no developer program, public API, SDK, or machine-readable API contract.
url: https://raw.githubusercontent.com/api-evangelist/bivacor/refs/heads/main/apis.yml
image: https://bivacor.com/wp-content/uploads/2024/02/BIVACOR_Logo-300x64.jpg
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-08-07'
modified: '2026-08-07'
tags:
- Company
- Medical Devices
- Health Care
- Cardiology
- Heart Failure
- Total Artificial Heart
- Mechanical Circulatory Support
- Medical Technology
- Clinical Trials
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/bivacor-domain-security.yml
- type: Conformance
  url: conformance/bivacor-conformance.yml
- type: LLMsTxt
  url: llms/bivacor-llms.txt
- type: Website
  url: https://bivacor.com/
- type: Blog
  url: https://bivacor.com/news/
- type: BlogRSS
  url: https://bivacor.com/feed/
- type: Press
  url: https://bivacor.com/media-coverage/
- type: Publications
  url: https://bivacor.com/publications/
- type: Careers
  url: https://jobs.ashbyhq.com/bivacor-inc
- type: Contact
  url: https://bivacor.com/#contact
- type: Support
  url: mailto:admin@bivacor.com
- type: LinkedIn
  url: https://www.linkedin.com/company/bivacor-pty-ltd
- type: Twitter
  url: https://x.com/bivacor
- type: SecondaryMarket
  url: https://www.nasdaqprivatemarket.com/
x-enrichment:
  date: '2026-08-07'
  status: minimal
  artifacts_added: 4
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: BiVACOR is a clinical-stage medical device manufacturer whose product is an implantable titanium total artificial
    heart, not software; bivacor.com is a single-page WordPress marketing site whose 15-URL sitemap contains no developer,
    API or documentation path, and api./developer./docs./portal./status.bivacor.com have no DNS record at all - the only 200
    on any contract-discovery path is /wp-json/, the stock WordPress REST API that ships enabled by default and is not a product
    API.
  evidence:
  - url: https://bivacor.com/openapi.json
    status: 404
  - url: https://bivacor.com/.well-known/agent-card.json
    status: 404
  - url: https://bivacor.com/.well-known/security.txt
    status: 404
  - url: https://bivacor.com/llms.txt
    status: 404
  - url: https://bivacor.com/sitemap.xml
    status: 200
  checked: '2026-08-07'